AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS.

Paulos Gebrehiwet,Lisa Meng,Stacy A Rudnicki,Phil Sarocco,Jenny Wei,Andrew A Wolff,Michael Butzner,Adriano Chiò,Jinsy A Andrews,Angela Genge,Dyfrig A Hughes,Carlayne E Jackson,Noah Lechtzin,Timothy M Miller,Jeremy M Shefner

Journal of medical economics（2023）

引用 1|浏览19
暂无评分
摘要
NCT03160898.
更多
查看译文
关键词
ALS,EQ-5D-5L,I,I1,I10,I19,Randomized clinical trial,amyotrophic lateral sclerosis,health utilities,reldesemtiv
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要